Clinical trial

DE-111 Against Timolol Ophthalmic Solution 0.5%

NCT01342094

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-05-01

PhasePHASE3

Study timeline

Study start (unknown)2011-05-01Date precision: month

Registry last updated2015-07-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Open Angle Glaucomaunresolved

Ocular Hypertensionunresolved

Interventions

DE-111 ophthalmic solutionDRUG

Timolol ophthalmic solution 0.5%DRUG

Placebo ophthalmic solutionDRUG

Sponsors & collaborators

Santen Pharmaceutical Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01342094 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.